Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NULL
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 0
  • Beta: 0.03

Polarean Imaging gets another research unit order

By Josh White

Date: Monday 10 May 2021

LONDON (ShareCast) - (Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a '9820 Xenon Polariser' system from the University of British Columbia (UBC), it announced on Monday.
The AIM-traded firm said it would be the second system installation at UBC, following the original order in November 2019 which was initially installed at BC Children's Hospital, while construction was carried out on its intended original site at St. Paul's.

As with the original system, the company said the new unit would continue to support UBC's pulmonary disease research programme using hyperpolarised gas imaging.

BC Children's is a major paediatric research and teaching hospital, and is the "most well-known facility" in the province for dealing in juvenile health, the board said.

"We value our long-standing relationship with UBC, a globally recognised research group, and we are excited that they are adding an additional polariser system to expand their research into the clinical applications of this emerging and much needed technology," said chief executive officer Richard Hullihen.

"We are also pleased to be able to continue to expand our paediatric research cluster, which also includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital."

At 1155 BST, shares in Polarean Imaging were up 5.88% at 97.41p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NULL
52 Week Low 1.00p
Volume 0
Shares Issued 1,207.03m
Beta 0.03

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

POLX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page